The latest ASCO podcast on the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer - Dana-Farber's Breast Oncology Center

The latest ASCO podcast on the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared on X/Twitter:

“Listen to the latest ASCO podcast where Dr. Angela DeMichele, Dr. Lynn Henry, and Dr. Harold Burstein discuss the rapid guideline update on endocrine and targeted therapy for HR+, HER2+ metastatic breast cancer.
Listen here.”

Image

Source: Dana-Farber’s Breast Oncology Center /X

 

Angela DeMichele ASCO ASCO Guidelines podcast Breast Cancer cancer Dana-Farber Breast Oncology Center endocrine therapy Harold Burstein HR+/HER2- breast cancer Lynn Henry metastatic breast cancer OncoDaily Oncology targeted therapy